ViroPharma is currently conducting two Phase 2 dose ranging studies of oral maribavir at one of three doses in transplant recipients.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViroPharma-Provides-Update-From-Ongoing-Phase-2-St/ArticleNewsFeed/Article/detail/816901?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViroPharma-Provides-Update-From-Ongoing-Phase-2-St/ArticleNewsFeed/Article/detail/816901?ref=25
No comments:
Post a Comment